Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.
Miller, James
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma. [electronic resource] - Journal of neurosurgery Aug 2010 - 280-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1933-0693
10.3171/2009.11.JNS09901 doi
Animals
Astrocytoma--immunology
Brain Neoplasms--immunology
CD27 Ligand--immunology
CD8-Positive T-Lymphocytes--cytology
Cell Division--physiology
Cell Line, Tumor
Disease Models, Animal
Immunotherapy--methods
Interferon-gamma--metabolism
Lymphocyte Depletion
Mice
Mice, Inbred Strains
Neoplasm Invasiveness--pathology
Solubility
Spleen--cytology
Survival Rate
Transfection
Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma. [electronic resource] - Journal of neurosurgery Aug 2010 - 280-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1933-0693
10.3171/2009.11.JNS09901 doi
Animals
Astrocytoma--immunology
Brain Neoplasms--immunology
CD27 Ligand--immunology
CD8-Positive T-Lymphocytes--cytology
Cell Division--physiology
Cell Line, Tumor
Disease Models, Animal
Immunotherapy--methods
Interferon-gamma--metabolism
Lymphocyte Depletion
Mice
Mice, Inbred Strains
Neoplasm Invasiveness--pathology
Solubility
Spleen--cytology
Survival Rate
Transfection